Ivy Kadzo Kombe

Ivy Kadzo Kombe

Auto-generated profile, based on publicly available information

Ivy Kadzo Kombe

KEMRI-Wellcome Trust Research Programme

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Science
Verified
Journal Article
Open access
SBSamuel P. C. Brand
Samuel P. C. Brand
JOJohn Ojal
John Ojal
RARabia Aziza
Rabia Aziza
VWVincent Omondi Were
Vincent Omondi Were
EOEmelda A. Okiro
Emelda A. Okiro
EBEdwine Barasa
Edwine Barasa
SARS-CoV-2: To have or to have not: In June 2021, official records in Kenya showed fewer than 4000 confirmed deaths and 180,000 confirmed cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These data tend to reflect the economically advantaged strata of society who can afford smartphones and have access to medical attention and tests. Brand et al . developed an epidemiological model to estimate the impact of the pandemic in Kenya, the population of which was split into two socioeconomic strata. The authors predicted that 75% of the Kenyan population (about 39 million people) had been exposed to the virus by June 2021. If a fourth wave of infection is observed in the future, it would likely be driven by a variant with enhanced transmissibility or natural immune escape. —CA

22 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JNJoyce U Nyiro
Joyce U Nyiro
IKIvy K Kombe
Ivy K Kombe
CSCharles J Sande
Charles J Sande
JKJames Kipkoech
James Kipkoech
PKPatience K Kiyuka
Patience K Kiyuka
DND James Nokes
D James Nokes
Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease in early life and a target for vaccine prevention. Data on the age-prevalence of RSV specific antibodies will inform on optimizing vaccine delivery. Archived plasma samples were randomly selected within age strata from 960 children less than 145 months of age admitted to Kilifi County Hospital pediatric wards between 2007 and 2010. Samples were tested for antibodies to RSV using crude virus IgG ELISA. Seroprevalence (and 95% confidence intervals) was estimated as the proportion of children with specific antibodies above a defined cut-off level. Nested catalytic models were used to explore different assumptions on antibody dynamics and estimate the rates of decay of RSV specific maternal antibody and acquisition of infection with age, and the average age of infection. RSV specific antibody prevalence was 100% at age 0-<1month, declining rapidly over the first 6 months of life, followed by an increase in the second half of the first year of life and beyond. Seroprevalence was lowest throughout the age range 5–11 months; all children were seropositive beyond 3 years of age. The best fit model to the data yielded estimates for the rate of infection of 0.78/person/year (95% CI 0.65–0.97) and 1.69/person/year (95% CI 1.27–2.04) for ages 0-<1 year and 1-<12 years, respectively. The rate of loss of maternal antibodies was estimated as 2.54/year (95% CI 2.30–2.90), i.e. mean duration 4.7 months. The mean age at primary infection was estimated at 15 months (95% CI 13–18). The rate of decay of maternal antibody prevalence and subsequent age-acquisition of infection are rapid, and the average age at primary infection early. The vaccination window is narrow, and suggests optimal targeting of vaccine to infants 5 months and above to achieve high seroconversion.

1 June 2019 in Epidemics
Verified
Journal Article
Open access
IKIvy K. Kombe
Ivy K. Kombe
PMPatrick K Munywoki
Patrick K Munywoki
MBMarc Baguelin
Marc Baguelin
DND. James Nokes
D. James Nokes
GMGraham F. Medley
Graham F. Medley
Respiratory syncytial virus (RSV) causes a significant respiratory disease burden in the under 5 population. The transmission pathway to young children is not fully quantified in low-income settings, and this information is required to design interventions. We used an individual level transmission model to infer transmission parameters using data collected from 493 individuals distributed across 47 households over a period of 6 months spanning the 2009/2010 RSV season. A total of 208 episodes of RSV were observed from 179 individuals. We model competing transmission risk from within household exposure and community exposure while making a distinction between RSV groups A and B. We find that 32-53% of all RSV transmissions are between members of the same household; the rate of pair-wise transmission is 58% (95% CrI: 30-74%) lower in larger households (≥8 occupants) than smaller households; symptomatic individuals are 2-7 times more infectious than asymptomatic individuals i.e. 2.48 (95% CrI: 1.22-5.57) among symptomatic individuals with low viral load and 6.7(95% CrI: 2.56-16) among symptomatic individuals with high viral load; previous infection reduces susceptibility to re-infection within the same epidemic by 47% (95% CrI: 17%-68%) for homologous RSV group and 39% (95%CrI: -8%-69%) for heterologous group; RSV B is more frequently introduced into the household, and RSV A is more rapidly transmitted once in the household. Our analysis presents the first transmission modelling of cohort data for RSV and we find that it is important to consider the household social structuring and household size when modelling transmission. The increased infectiousness of symptomatic individuals implies that a vaccine against RSV related disease would also have an impact on infection transmission. Together, the weak cross immunity between RSV groups and the possibility of different transmission niches could form part of the explanation for the group co-existence.

14 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
SBSamuel P. C. Brand
Samuel P. C. Brand
RARabia Aziza
Rabia Aziza
IKIvy K. Kombe
Ivy K. Kombe
CACharles Agoti
Charles Agoti
JHJoseph Hilton
Joseph Hilton
EBEdwine W. Barasa
Edwine W. Barasa
Background: The first COVID-19 case in Kenya was confirmed on March 13 th , 2020. Here, we provide forecasts for the potential incidence rate, and magnitude, of a COVID-19 epidemic in Kenya based on the observed growth rate and age distribution of confirmed COVID-19 cases observed in China, whilst accounting for the demographic and geographic dissimilarities between China and Kenya. Methods: We developed a modelling framework to simulate SARS-CoV-2 transmission in Kenya, KenyaCoV. KenyaCoV was used to simulate SARS-CoV-2 transmission both within, and between, different Kenyan regions and age groups. KenyaCoV was parameterized using a combination of human mobility data between the defined regions, the recent 2019 Kenyan census, and estimates of age group social interaction rates specific to Kenya. Key epidemiological characteristics such as the basic reproductive number and the age-specific rate of developing COVID-19 symptoms after infection with SARS-CoV-2, were adapted for the Kenyan setting from a combination of published estimates and analysis of the age distribution of cases observed in the Chinese outbreak. Results: We find that if person-to-person transmission becomes established within Kenya, identifying the role of subclinical, and therefore largely undetected, infected individuals is critical to predicting and containing a very significant epidemic. Depending on the transmission scenario our reproductive number estimates for Kenya range from 1.78 (95% CI 1.44 −2.14) to 3.46 (95% CI 2.81-4.17). In scenarios where asymptomatic infected individuals are transmitting significantly, we expect a rapidly growing epidemic which cannot be contained only by case isolation. In these scenarios, there is potential for a very high percentage of the population becoming infected (median estimates: >80% over six months), and a significant epidemic of symptomatic COVID-19 cases. Exceptional social distancing measures can slow transmission, flattening the epidemic curve, but the risk of epidemic rebound after lifting restrictions is predicted to be high.

3 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
JOJohn Ojal
John Ojal
SBSamuel P. C. Brand
Samuel P. C. Brand
VWVincent Omondi Were
Vincent Omondi Were
EOEmelda A Okiro
Emelda A Okiro
IKIvy Kadzo Kombe
Ivy Kadzo Kombe
DND. James. Nokes
D. James. Nokes
Policy makers in Africa need robust estimates of the current and future spread of SARS-CoV-2. Data suitable for this purpose are scant. We used national surveillance PCR test, serological survey and mobility data to develop and fit a county-specific transmission model for Kenya. We estimate that the SARS-CoV-2 pandemic peaked before the end of July 2020 in the major urban counties, with 34 - 41% of residents infected, and will peak elsewhere in the country within 2-3 months. Despite this penetration, reported severe cases and deaths are low. Our analysis suggests the COVID-19 disease burden in Kenya may be far less than initially feared. A similar scenario across sub-Saharan Africa would have implications for balancing the consequences of restrictions with those of COVID-19.

9 February 2021 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
DNDickson Machira Nyaguthii
Dickson Machira Nyaguthii
GOGrieven P. Otieno
Grieven P. Otieno
IKIvy K. Kombe
Ivy K. Kombe
DKDorothy Koech
Dorothy Koech
MMMartin Mutunga
Martin Mutunga
PMPatrick K Munywoki
Patrick K Munywoki
Background: The natural history and transmission patterns of endemic human coronaviruses are of increased interest following the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Methods: In rural Kenya 483 individuals from 47 households were followed for six months (2009-10) with nasopharyngeal swabs collected twice weekly regardless of symptoms. A total of 16,918 swabs were tested for human coronavirus (hCoV) OC43, NL63 and 229E and other respiratory viruses using polymerase chain reaction. Results: From 346 (71.6%) household members, 629 hCoV infection episodes were defined, with 36.3% being symptomatic: varying by hCoV type and decreasing with age. Symptomatic episodes (aHR=0.6 (95% CI:0.5-0.8) or those with elevated peak viral load (medium aHR=0.4 (0.3-0.6); high aHR=0.31 (0.2-0.4)) had longer viral shedding compared to their respective counterparts. Homologous reinfections were observed in 99 (19.9%) of 497 first infections. School-age children (55%) were the most common index cases with those having medium (aOR=5.3 (2.3 – 12.0)) or high (8.1 (2.9 - 22.5)) peak viral load most often generating secondary cases. Conclusion: Household coronavirus infection was common, frequently asymptomatic and mostly introduced by school-age children. Secondary transmission was influenced by viral load of index cases. Homologous-type reinfection was common. These data may be insightful for SARS-CoV-2.